دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Cardiometabolic disease and multiple long-term condition healthcare provision in Sub-Saharan Africa: Opportunities for new models of care in the post-COVID era
doi : 10.1016/j.dsx.2022.102681
Volume 17, Issue 1, January 2023, 102681
The ratio of free triiodothyronine to free thyroxine is regulated differently in patients with type 2 diabetes mellitus treated and not treated with sodium glucose cotransporter 2 inhibitors
Shuichi Okada a, b, *, Atsushi Isoda a , Hiroto Hoshi a , Junichi Okada c , Kazuya Okada d , Eijiro Yamada e , Tsugumichi Saito e , Takuya Watanabe f , Koji Kikkawa b , Kihachi Ohshima b
doi : 10.1016/j.dsx.2022.102704
Volume 17, Issue 1, January 2023, 102704
Fasting Ramadan in patients with T1DM – Saudi Arabia versus other countries during the COVID-19 pandemic
Reem M. Alamoudi a, *, Naji J. Aljohani b , Eman M. Alfadhli c , Naweed Alzaman c , Abdulaziz F. Alfadhly d , Majd-Aldeen Kallash e , Abdulwadod M. Alshenqete f , Mohammed A. Batais g , Mansour Alharbi h , Aishah A. Ekhzaimy i , Eman Sheshah j , Muhammad Yakoob Ahmedani k , Mehmet Akif Buyukbese l , Inass Shaltout m , Kamel Hemaida n, o , Jamal Belkhadir p , Bachar Afandi q , Khadija Hafidh r , Zanariah Hussein s , Nancy S. Elbarbary t , Mohamed Hassanein
doi : 10.1016/j.dsx.2022.102676
Volume 17, Issue 1, January 2023, 102676
To compare Saudi Arabia with other countries regarding patient attitudes towards fasting Ramadan and complications related to fasting during the COVID-19 pandemic.
Effect of empagliflozin in patients with type 2 diabetes during Ramadan on volume status, ketonaemia, and hypoglycaemia
Kian Guan Goh a, *, Miza Hiryanti Zakaria a , Raja Nurazni Raja Azwan a , Kiren Kaur Bhajan Singh a , Muhammad Hazrul Badrul Hisham a , Zanariah Hussein
doi : 10.1016/j.dsx.2022.102680
Volume 17, Issue 1, January 2023, 102680
Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes
Andrzej S. Januszewski a, b, *, 2 , Pawel Niedzwiecki c, 2 , Nirupa Sachithanandan b , Glenn M. Ward b , Connie S. Karschimkus b , David N. O'Neal b , Dorota A. Zozulinska-Ziolkiewicz c, 1 , Aleksandra A. Uruska c, 1 , Alicia J. Jenkins
doi : 10.1016/j.dsx.2022.102691
Volume 17, Issue 1, January 2023, 102691
Low insulin sensitivity (IS) increases Type 1 diabetes (T1D) complication risk and can be estimated by simple formulae developed from complex euglycemic hyperinsulinaemic clamp studies. We aimed to validate these formulae using independent clamp data.
Diabetes disease detection and classification on Indian demographic and health survey data using machine learning methods
Puneeth N. Thotad a, *, Geeta R. Bharamagoudar b , Basavaraj S. Anami
doi : 10.1016/j.dsx.2022.102690
Volume 17, Issue 1, January 2023, 102690
Diabetes mellitus has become one of the out brakes causing major health issues in developing countries like India. The need for leveraging technology is felt in diabetes management. The main objective of this work is to deploy machine learning methods for the detection and classification of diabetes having clinical relevance.
Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial
Sima Jafarirad a, b , Reza Goodarzi a, b, *, Narges Mohammadtaghvaei c , Maryam Dastoorpoor d , Pejman Alavinejad
doi : 10.1016/j.dsx.2022.102693
Volume 17, Issue 1, January 2023, 102693
Pomegranate as a functional food has various properties and effects on health. The aim of the study was to evaluate the effect of pomegranate extract on serum levels of liver enzymes, hepatokines, interleukin-6 (IL-6), and total antioxidant capacity in non-alcoholic fatty liver disease (NAFLD).
Down referral and assessing comprehensive diabetes care in primary care settings: An operational research from India
Jeby Jose Olickal a, b , Palanivel Chinnakali a, *, B.S. Suryanarayana c , S. Rajanarayanan c , T. Vivekanandhan d , Ganesh Kumar Saya a , Kalaiselvan Ganapathy e , D.K.S. Subrahmanyam
doi : 10.1016/j.dsx.2022.102694
Volume 17, Issue 1, January 2023, 102694
In this study, we aimed to refer eligible (patients with stable blood sugar and without any history of cardiovascular events or proliferative retinopathy) and willing persons with diabetes (PwDs) to primary healthcare centers (PHCs) from tertiary care and to compare the care indicators.
Assessment of determining factors for severity of NeoCOVIDiabetes in India: A pan India multicentric retrospective study
Anuj Maheshwari a, *, Dhruvi Hasnani b , Meenakshi Bhattacharya c , M. Mukhyaprana Prabhu d , Divya Saxena e , Bidita Khandelwal f , C.L. Nawal g , Brij Mohan Makkar h , Sajid Ansari i , Prahlad Chawla j , Prabhat Agrawal k , Ashish Saxena l , Narsingh Verma m , Banshi Saboo n , Vipul Chavda b , Uday Pratap Singh o , Vanshika Arora
doi : 10.1016/j.dsx.2022.102692
Volume 17, Issue 1, January 2023, 102692
There is a bidirectional relationship between COVID-19 and diabetes. The primary objective of this study was to estimate the prevalence of patients newly detected to have diabetes (NDD) who recovered from COVID-19 in India whilst comparing NDD with patients without diabetes (ND) and those who have known to have diabetes (KD) in terms of glycemic status pre- and post-COVID with disease severity.
Postpartum weight retention and its association with socio-demographic and obstetrics correlates: A cross-sectional hospital-based preliminary survey in India
Divjyot Kaur a , Piyush Ranjan b, *, Wareesha Anwar a , Aditi Verma a , Archana Kumari c , Ashish Datt Upadhyay d , Anita Malhotra e , Komal Kushwaha b , Mayank Mani Pandey b , Gaurishankar Kaloiya
doi : 10.1016/j.dsx.2022.102701
Volume 17, Issue 1, January 2023, 102701
Postpartum weight retention can predispose women to an elevated risk of obesity and associated complications. The study aims to assess the magnitude of postpartum weight retention and its association with socio-demographic and obstetrics correlates.
Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis
Deep Dutta a, *, Deepak Khandelwal b , Manoj Kumar c , Meha Sharma
doi : 10.1016/j.dsx.2022.102695
Volume 17, Issue 1, January 2023, 102695
Glucokinase has a critical role in regulating glucose homeostasis in humans, and has been a target for diabetes drug development since 1990s. Dorzagliatin is a novel allosteric dual glucokinase activator targeting both pancreatic and hepatic glucokinase.
Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
Deep Dutta a, *, Saptarshi Bhattacharya b , Manoj Kumar c , Priyankar K. Datta d , Ritin Mohindra e , Meha Sharma
doi : 10.1016/j.dsx.2022.102697
Volume 17, Issue 1, January 2023, 102697
No meta-analysis has analysed the safety and efficacy of lobeglitazone in type-2 diabetes (T2DM). We undertook this meta-analysis to address this knowledge-gap.
Dietary approach for management of Type-2 diabetes: An overview of glycemic indices of commonly consumed foods in Nigeria
Stanley I.R. Okoduwa a, c, *, Ibrahim Abdulwaliyu
doi : 10.1016/j.dsx.2022.102698
Volume 17, Issue 1, January 2023, 102698
The global prevalence of diabetes mellitus is on the increase, and Africa, particularly Nigeria is not left out. The management of the disease using a diabetes drug is often a hard choice to make for many. Information on the right food is inevitably important, as eating some type of food and avoiding or limiting some could help manage diabetes. Therefore, this study investigated glycemic indices of commonly consumed staples in Nigeria.
Glucagon-like peptide 1-receptor agonists and A1c: Good for the heart but less so for the eyes?
Stewart G. Albert*, Emily M. Wood, Vaishaliben Ahir
doi : 10.1016/j.dsx.2022.102696
Volume 17, Issue 1, January 2023, 102696
Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis
Shashank R. Joshi a, 1 , Saibal Das b, c, 1 , Suja Xaviar d, 1 , Shambo Samrat Samajdar e, *, Indranil Saha b , Sougata Sarkar e , Shatavisa Mukherjee e , Santanu Kumar Tripathi f , Jyotirmoy Pal g , Nandini Chatterjee
doi : 10.1016/j.dsx.2022.102703
Volume 17, Issue 1, January 2023, 102703
This systematic review and meta-analysis was conducted to evaluate the efficacy and safety of lobeglitazone as compared to the standard of care (SOC) in patients with type 2 diabetes mellitus (T2DM).
Corrigendum to “Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes� [Diabetes Metabol Syndr Clin Res Rev 17(1) (2023) 102691]
doi : 10.1016/j.dsx.2022.102700
Volume 17, Issue 1, January 2023, 102700
